2024 annual financial data
INmune Bio 2024 Net margin
Direct answer
Net margin was -300,585.71%.
Operating income was -42,635,000 USD and net income was -42,082,000 USD.
Operating cash flow was -33,361,000 USD.
Get free INmune Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,000 USD
- Operating income
- -42,635,000 USD
- Net income
- -42,082,000 USD
- Operating cash flow
- -33,361,000 USD